India · Delayed Price · Currency is INR Evervie Health Statistics
Total Valuation
Evervie Health has a market cap or net worth of INR 10.34 billion. The enterprise value is 14.19 billion.
| Market Cap | 10.34B |
| Enterprise Value | 14.19B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evervie Health has 260.40 million shares outstanding. The number of shares has decreased by -7.94% in one year.
| Current Share Class | 260.40M |
| Shares Outstanding | 260.40M |
| Shares Change (YoY) | -7.94% |
| Shares Change (QoQ) | -2.74% |
| Owned by Insiders (%) | 8.97% |
| Owned by Institutions (%) | n/a |
| Float | 87.05M |
Valuation Ratios
The trailing PE ratio is 201.91.
| PE Ratio | 201.91 |
| Forward PE | n/a |
| PS Ratio | 8.76 |
| PB Ratio | 2.60 |
| P/TBV Ratio | 279.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 284.11 |
| EV / Sales | 12.01 |
| EV / EBITDA | 57.94 |
| EV / EBIT | 174.71 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.07 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 10.05 |
| Debt / FCF | n/a |
| Interest Coverage | 0.26 |
Financial Efficiency
Return on equity (ROE) is -3.23% and return on invested capital (ROIC) is 0.46%.
| Return on Equity (ROE) | -3.23% |
| Return on Assets (ROA) | 0.66% |
| Return on Invested Capital (ROIC) | 0.46% |
| Return on Capital Employed (ROCE) | 0.94% |
| Weighted Average Cost of Capital (WACC) | 7.09% |
| Revenue Per Employee | 59.07M |
| Profits Per Employee | 2.50M |
| Employee Count | 20 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.39 |
Taxes
In the past 12 months, Evervie Health has paid 28.17 million in taxes.
| Income Tax | 28.17M |
| Effective Tax Rate | 69.87% |
Stock Price Statistics
The stock price has increased by +34.96% in the last 52 weeks. The beta is 0.65, so Evervie Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | +34.96% |
| 50-Day Moving Average | 53.70 |
| 200-Day Moving Average | 35.52 |
| Relative Strength Index (RSI) | 31.20 |
| Average Volume (20 Days) | 1,453,203 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Evervie Health had revenue of INR 1.18 billion and earned 49.95 million in profits. Earnings per share was 0.20.
| Revenue | 1.18B |
| Gross Profit | 893.70M |
| Operating Income | 92.05M |
| Pretax Income | 40.32M |
| Net Income | 49.95M |
| EBITDA | 242.04M |
| EBIT | 92.05M |
| Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 513.37 million in cash and 2.57 billion in debt, with a net cash position of -2.06 billion or -7.90 per share.
| Cash & Cash Equivalents | 513.37M |
| Total Debt | 2.57B |
| Net Cash | -2.06B |
| Net Cash Per Share | -7.90 |
| Equity (Book Value) | 3.97B |
| Book Value Per Share | 8.38 |
| Working Capital | 99.76M |
Cash Flow
In the last 12 months, operating cash flow was -234.65 million and capital expenditures -281.68 million, giving a free cash flow of -516.33 million.
| Operating Cash Flow | -234.65M |
| Capital Expenditures | -281.68M |
| Depreciation & Amortization | 149.99M |
| Net Borrowing | 1.96B |
| Free Cash Flow | -516.33M |
| FCF Per Share | -1.98 |
Margins
Gross margin is 75.65%, with operating and profit margins of 7.79% and 4.23%.
| Gross Margin | 75.65% |
| Operating Margin | 7.79% |
| Pretax Margin | 3.41% |
| Profit Margin | 4.23% |
| EBITDA Margin | 20.49% |
| EBIT Margin | 7.79% |
| FCF Margin | n/a |
Dividends & Yields
Evervie Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.94% |
| Shareholder Yield | 7.94% |
| Earnings Yield | 0.50% |
| FCF Yield | -4.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 24, 1999. It was a forward split with a ratio of 2.
| Last Split Date | Mar 24, 1999 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |